SMTL ID : 6oim.1

Crystal Structure of human KRAS G12C covalently bound to AMG 510

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.65 Å

Oligo State

monomer

Ligands

1 x MG: MAGNESIUM ION(Non-covalent)

MG.1: 3 residues within 4Å: Chain A: S.31, D.71 Ligands: GDP.2 5 PLIP interactions: 1 interactions with chain A, 4 Ligand-Water interactions Metal complexes: A:S.31, H2O.1, H2O.1, H2O.2, H2O.2

1 x GDP: GUANOSINE-5'-DIPHOSPHATE(Non-covalent)

GDP.2: 20 residues within 4Å: Chain A: A.25, C.26, G.27, V.28, G.29, K.30, S.31, A.32, F.42, D.44, Y.46, N.130, K.131, D.133, L.134, S.159, A.160, K.161 Ligands: MG.1, MOV.3 22 PLIP interactions: 22 interactions with chain A Hydrogen bonds: A:A.25, A:G.27, A:V.28, A:G.29, A:K.30, A:S.31, A:A.32, A:D.44, A:N.130, A:K.131, A:K.131, A:A.160, A:K.161 Water bridges: A:S.31, A:S.31, A:Y.46, A:Y.46, A:K.161 Salt bridges: A:K.30, A:D.133 pi-Stacking: A:F.42, A:F.42

1 x MOV: AMG 510 (bound form)(Covalent)

MOV.3: 18 residues within 4Å: Chain A: V.23, G.24, C.26, K.30, P.48, T.72, A.73, G.74, Q.75, E.76, E.77, R.82, M.86, H.109, Y.110, Q.113, V.117 Ligands: GDP.2 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:P.48, A:E.77, A:H.109, A:Y.110, A:Y.110, A:Q.113, A:Q.113, A:V.117 Hydrogen bonds: A:K.30, A:E.76, A:Y.110 Water bridges: A:Q.113 pi-Stacking: A:Y.110, A:Y.110

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Canon, J. et al., The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity. Nature (2019)

Release Date

2019-11-06

Peptides

GTPase KRas: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

GTPase KRas

Related Entries With Identical Sequence